Patents by Inventor Manon Couture

Manon Couture has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110104753
    Abstract: The present invention provides a recombinant soluble trimeric hemagglutinin (rHA) protein comprising a hemagglutinin ectodomain and an oligomerization domain. The rHA is produced as a soluble homotrimer, and may further comprises a signal peptide and/or an endoplasmic reticulum (ER) retention signal. The invention is also directed to nucleic acids encoding the rHA of the invention, as well as vectors and chimeric constructs comprising the nucleic acid. Methods of producing the rHA are also provided. The rHA described herein may be used to formulate influenza vaccines, or may be used to enrich existing vaccines.
    Type: Application
    Filed: July 7, 2009
    Publication date: May 5, 2011
    Applicant: MEDICAGO INC.
    Inventors: Manon Couture, Nathalie Landry, Louis-Philippe Vezina, Michéle Dargis
  • Publication number: 20100310604
    Abstract: A method for synthesizing influenza virus-like particles (VLPs) within a plant or a portion of a plant is provided. The method involves expression of influenza HA in plants and the purification by size exclusion chromatography. The invention is also directed towards a VLP comprising influenza HA protein and plants lipids. The invention is also directed to a nucleic acid encoding influenza HA as well as vectors. The VLPs may be used to formulate influenza vaccines, or may be used to enrich existing vaccines.
    Type: Application
    Filed: January 12, 2009
    Publication date: December 9, 2010
    Applicant: MEDICAGO INC.
    Inventors: Marc-André D'Aoust, Manon Couture, Frédéric Ors, Sonia Trépanier, Pierre-Olivier Lavoie, Michéle Dargis, Louis-Philippe Vézina, Nathalie Landry
  • Publication number: 20100239610
    Abstract: A method for synthesizing influenza virus-like particles (VLPs) within a plant or a portion of a plant is provided. The method involves expression of influenza HA in plants and the purification by size exclusion chromatography. The invention is also directed towards a VLP comprising influenza HA protein and plants lipids. The invention is also directed to a nucleic acid encoding influenza HA as well as vectors. The VLPs may be used to formulate influenza vaccines, or may be used to enrich existing vaccines.
    Type: Application
    Filed: July 11, 2008
    Publication date: September 23, 2010
    Applicant: MEDICAGO INC.
    Inventors: Marc-André D'Aoust, Manon Couture, Frédéric Ors, Sonia Trépanier, Pierre-Olivier Lavoie, Michéle Dargis, Louis-Philippe Vézina, Nathalie Landry